Ginsenoside Rh2 epigenetically regulates cell-mediated immune pathway to inhibit proliferation of MCF-7 breast cancer cells

BACKGROUND: Ginsenoside Rh2 has been known to enhance the activity of immune cells, as well as to inhibit the growth of tumor cells. Although the repertoire of genes regulated by Rh2 is well-known in many cancer cells, the epigenetic regulation has yet to be determined, especially for comprehensive...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hyunkyung, Lee, Seungyeon, Jeong, Dawoon, Kim, Sun Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187096/
https://www.ncbi.nlm.nih.gov/pubmed/30337805
http://dx.doi.org/10.1016/j.jgr.2017.05.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187096/
https://www.ncbi.nlm.nih.gov/pubmed/30337805
http://dx.doi.org/10.1016/j.jgr.2017.05.003

Ejemplares similares